EAM
EFG Asset Management Portfolio holdings
AUM
$708M
This Quarter Return
+8.01%
1 Year Return
+34.17%
3 Year Return
+178.74%
5 Year Return
–
10 Year Return
–
AUM
$732M
AUM Growth
+$732M
(+23%)
Cap. Flow
+$119M
Cap. Flow
% of AUM
16.25%
Top 10 Holdings %
Top 10 Hldgs %
20.87%
Holding
199
New
12
Increased
128
Reduced
34
Closed
25
Top Buys
| 1 |
Palantir
PLTR
|
$4.87M |
| 2 |
Glaukos
GKOS
|
$4.7M |
| 3 |
Lam Research
LRCX
|
$4.33M |
| 4 |
Arista Networks
ANET
|
$4.13M |
| 5 |
Insmed
INSM
|
$3.92M |
Top Sells
| 1 |
Tesla
TSLA
|
$4.43M |
| 2 |
Transmedics
TMDX
|
$3.25M |
| 3 |
Sarepta Therapeutics
SRPT
|
$3.04M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$2.94M |
| 5 |
Legend Biotech
LEGN
|
$2.88M |
Sector Composition
| 1 | Technology | 29.68% |
| 2 | Healthcare | 25.52% |
| 3 | Industrials | 12.74% |
| 4 | Consumer Discretionary | 11.74% |
| 5 | Financials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Zscaler
ZS
$43.1B
| $2.12M | 0.29% |
11,724
-496
| -4% | -$89.5K |
|
152
Lennar Class A
LEN
$34.5B
| $2.1M | 0.29% |
15,376
+1,372
| +10% | +$187K |
|
153
UFP Technologies
UFPT
$1.62B
| $2.09M | 0.29% |
8,537
+3,155
| +59% | +$772K |
|
154
Garmin
GRMN
$46.5B
| $2.08M | 0.28% |
10,066
+4,034
| +67% | +$832K |
|
155
Copart
CPRT
$47.2B
| $2.04M | 0.28% |
35,471
-1,446
| -4% | -$83K |
|
156
PubMatic
PUBM
$396M
| $1.96M | 0.27% |
133,756
+49,133
| +58% | +$722K |
|
157
Spyre Therapeutics
SYRE
$996M
| $1.93M | 0.26% |
82,818
+30,608
| +59% | +$713K |
|
158
Levi Strauss
LEVI
$8.85B
| $1.88M | 0.26% |
108,854
+14,006
| +15% | +$242K |
|
159
NXP Semiconductors
NXPI
$59.2B
| $1.87M | 0.26% |
9,000
+737
| +9% | +$153K |
|
|
ONC
160
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $1.85M | 0.25% |
9,986
-3,489
| -26% | -$645K |
|
161
Immunovant
IMVT
$2.56B
| $1.83M | 0.25% |
73,981
+163
| +0.2% | +$4.04K |
|
162
Rocket Pharmaceuticals
RCKT
$354M
| $1.83M | 0.25% |
145,629
-98,791
| -40% | -$1.24M |
|
163
Snowflake
SNOW
$79.6B
| $1.83M | 0.25% |
+11,840
| New | +$1.83M |
|
164
Neurocrine Biosciences
NBIX
$13.8B
| $1.82M | 0.25% |
13,321
-14,190
| -52% | -$1.94M |
|
165
MSCI
MSCI
$43.9B
| $1.75M | 0.24% |
2,921
+1,062
| +57% | +$637K |
|
166
Cirrus Logic
CRUS
$5.86B
| $1.74M | 0.24% |
17,493
+6,459
| +59% | +$643K |
|
167
Fabrinet
FN
$11.8B
| $1.73M | 0.24% |
+7,849
| New | +$1.73M |
|
168
Charles River Laboratories
CRL
$8.04B
| $1.65M | 0.23% |
8,959
-2,845
| -24% | -$525K |
|
|
GAP
169
The Gap, Inc.
GAP
$8.21B
| $1.65M | 0.23% |
69,728
+26,046
| +60% | +$616K |
|
170
Coinbase
COIN
$78.2B
| $1.5M | 0.2% |
+6,042
| New | +$1.5M |
|
171
Apellis Pharmaceuticals
APLS
$3.48B
| $1.38M | 0.19% |
43,157
+10,087
| +31% | +$322K |
|
172
Piper Sandler
PIPR
$5.9B
| $1.25M | 0.17% |
+4,143
| New | +$1.25M |
|
173
SPX Corp
SPXC
$9.25B
| $1.24M | 0.17% |
+8,546
| New | +$1.24M |
|
174
Edgewise Therapeutics
EWTX
$1.51B
| $1.1M | 0.15% |
+41,338
| New | +$1.1M |
|
|
SMAR
175
DELISTED
Smartsheet Inc.
SMAR
| – | – |
-37,975
| Closed | -$2.1M |
|